EU approval for Sanofi’s diabetes combo
Sanofi-Aventis’ Suliqua has been approved in the European Union expanding treatment options for people with type II diabetes.
Read More
Tag: Zealand
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
- Fabentech secures French approval for Ricimed antidote
